Turquoise Health is a technology company.
Turquoise Health has raised $55.0M across 3 funding rounds.
Turquoise Health has raised $55.0M in total across 3 funding rounds.
# High-Level Overview
Turquoise Health is a SaaS platform that eliminates financial complexity in healthcare by providing price transparency data and managed care contracting solutions.[1][2] Founded in 2020 and based in San Diego, California, the company aggregates machine-readable pricing files from hospitals and payers to create actionable intelligence for healthcare organizations and consumers.[1][2]
The platform serves three primary constituencies: providers and health systems seeking to optimize pricing and negotiate insurance contracts more effectively; payers managing rate disclosures and contracting workflows; and patients shopping for care based on upfront pricing.[3] Turquoise Health addresses a critical pain point in healthcare administration—the opacity and complexity of medical pricing—by transforming regulatory compliance requirements (such as rate disclosure mandates) into a competitive advantage through superior data infrastructure and AI-powered analytics.[3]
# Origin Story
Turquoise Health was founded in 2020 by Chris Severn (CEO) and Adam Geitgey (CTO), who recognized an opportunity created by regulatory shifts requiring hospitals and payers to publish negotiated rates in machine-readable formats.[1][3] Rather than viewing this compliance burden as a problem, the founders built technology to make this previously inaccessible data useful and actionable.[3]
The company gained early traction by positioning itself as the bridge between regulatory requirements and business value. As healthcare organizations sought to comply with rate disclosure requirements, they simultaneously discovered Turquoise's ability to help them verify and optimize their own published prices—creating a positive feedback loop that strengthened the platform's data quality.[3] This early momentum attracted institutional investment, including a $30 million Series B round led by Adams Street Partners, validating the market opportunity and the company's technological approach.[3]
# Core Differentiators
# Role in the Broader Tech Landscape
Turquoise Health operates at the intersection of healthcare regulation, data infrastructure, and AI adoption—three powerful trends reshaping the industry. The company benefits from regulatory tailwinds: U.S. healthcare price transparency mandates have created an unprecedented volume of structured pricing data, yet most organizations lack tools to leverage it effectively.[3] This regulatory-to-opportunity gap is precisely where Turquoise operates.
The platform also exemplifies a broader shift toward vertical SaaS solutions in healthcare—software built specifically for the unique workflows and compliance requirements of healthcare organizations rather than generic enterprise tools.[2] As healthcare systems grapple with administrative waste and billing complexity, companies that can reduce friction while improving decision-making gain outsized influence.
Turquoise's emphasis on real-time data and AI-driven insights reflects the industry's maturation: healthcare is moving beyond static reporting toward dynamic, predictive analytics that enable faster negotiations and better pricing strategies.[3] By making contracting and pricing transparent and efficient, Turquoise influences not just individual organizations but the broader healthcare transaction ecosystem, potentially enabling real-time payments and reducing administrative overhead across the system.
# Quick Take & Future Outlook
Turquoise Health is positioned to become essential infrastructure in healthcare administration. As regulatory requirements for price transparency become global norms and healthcare organizations increasingly compete on cost efficiency, demand for the company's platform should accelerate. The integration of AI into contracting workflows—a nascent but rapidly expanding category—gives Turquoise first-mover advantage in a market that will likely see significant consolidation.
The company's trajectory suggests expansion beyond pricing into broader revenue cycle optimization and payer-provider collaboration tools. Success will depend on maintaining data quality as the platform scales, deepening AI capabilities to handle increasingly complex contracting scenarios, and expanding adoption among smaller providers and health plans currently underserved by enterprise solutions.
Ultimately, Turquoise Health's influence extends beyond its customer base: by making healthcare pricing transparent and negotiable, the company is reshaping how the industry transacts, potentially unlocking billions in administrative savings while improving consumer choice—a rare alignment of business value and systemic impact.
Turquoise Health has raised $55.0M in total across 3 funding rounds.
Turquoise Health's investors include Andreessen Horowitz, Jazz Venture Partners, 8VC, GreatPoint Ventures, Kenan Turnacioglu.
Turquoise Health has raised $55.0M across 3 funding rounds. Most recently, it raised $30.0M Series B in January 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2024 | $30.0M Series B | Andreessen Horowitz, Jazz Venture Partners | |
| May 1, 2022 | $20.0M Series A | Andreessen Horowitz, Jazz Venture Partners | |
| Jul 1, 2021 | $5.0M Seed | 8VC, Andreessen Horowitz, GreatPoint Ventures, Jazz Venture Partners, Kenan Turnacioglu |